Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Current Deferred Revenue (2022 - 2025)

Historic Current Deferred Revenue for Stemtech (STEK) over the last 4 years, with Q3 2025 value amounting to $88393.0.

  • Stemtech's Current Deferred Revenue changed N/A to $88393.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $88393.0, marking a year-over-year change of. This contributed to the annual value of $1463.0 for FY2024, which is 9738.93% down from last year.
  • According to the latest figures from Q3 2025, Stemtech's Current Deferred Revenue is $88393.0.
  • In the past 5 years, Stemtech's Current Deferred Revenue ranged from a high of $98249.0 in Q2 2025 and a low of $1463.0 during Q4 2024
  • For the 4-year period, Stemtech's Current Deferred Revenue averaged around $61533.5, with its median value being $75907.0 (2023).
  • Over the last 5 years, Stemtech's Current Deferred Revenue had its largest YoY gain of 7549.46% in 2024, and its largest YoY loss of 9738.93% in 2024.
  • Over the past 4 years, Stemtech's Current Deferred Revenue (Quarter) stood at $39170.0 in 2022, then surged by 43.07% to $56039.0 in 2023, then tumbled by 97.39% to $1463.0 in 2024, then skyrocketed by 5941.9% to $88393.0 in 2025.
  • Its Current Deferred Revenue was $88393.0 in Q3 2025, compared to $98249.0 in Q2 2025 and $6778.0 in Q1 2025.